BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30244234)

  • 1. Locoregional disease control after external beam radiotherapy in 91 patients with differentiated thyroid carcinoma and pT4 tumor stage - a single institution experience.
    Besic N; Dremelj M; Pilko G
    Radiol Oncol; 2018 Sep; 52(4):453-460. PubMed ID: 30244234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience.
    Besic N; Schwarzbartl-Pevec A; Vidergar-Kralj B; Crnic T; Gazic B; Marolt Music M
    BMC Cancer; 2016 Feb; 16():162. PubMed ID: 26921186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience.
    Ibrahimpasic T; Ghossein R; Carlson DL; Chernichenko N; Nixon I; Palmer FL; Lee NY; Shaha AR; Patel SG; Tuttle RM; Balm AJ; Shah JP; Ganly I
    Thyroid; 2013 Aug; 23(8):997-1002. PubMed ID: 23311700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative external beam radiotherapy for medullary thyroid carcinoma with high risk of locoregional relapse].
    Compagnon F; Zerdoud S; Rives M; Laprie A; Sarini J; Grunenwald S; Chaltiel L; Graff P
    Cancer Radiother; 2016 Jul; 20(5):362-9. PubMed ID: 27396902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of differentiated thyroid carcinoma studied in 500 patients.
    Lerch H; Schober O; Kuwert T; Saur HB
    J Clin Oncol; 1997 May; 15(5):2067-75. PubMed ID: 9164219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Retropharyngeal Lymph Node Metastases in Differentiated Thyroid Carcinoma.
    Harries V; McGill M; Tuttle RM; Shaha AR; Wong RJ; Shah JP; Patel SG; Ganly I
    Thyroid; 2020 May; 30(5):688-695. PubMed ID: 31910129
    [No Abstract]   [Full Text] [Related]  

  • 14. Aggressiveness of therapy and prognosis of patients with Hürthle cell papillary thyroid carcinoma.
    Besic N; Hocevar M; Zgajnar J; Petric R; Pilko G
    Thyroid; 2006 Jan; 16(1):67-72. PubMed ID: 16487016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer.
    Kim TH; Chung KW; Lee YJ; Park CS; Lee EK; Kim TS; Kim SK; Jung YS; Ryu JS; Kim SS; Cho KH; Shin KH
    Radiat Oncol; 2010 Aug; 5():69. PubMed ID: 20687967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy in well-differentiated thyroid cancer: is it underutilized?
    So K; Smith RE; Davis SR
    ANZ J Surg; 2016 Sep; 86(9):696-700. PubMed ID: 26573999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of external irradiation for locally advanced papillary thyroid cancer.
    Kim TH; Yang DS; Jung KY; Kim CY; Choi MS
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1006-12. PubMed ID: 12605980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Beam Radiation Therapy in pT4 Well-Differentiated Thyroid Cancer: A Population-Based Study of 405 Patients.
    Sit D; Koh WX; Shokoohi A; Raycraft T; Vu M; Hamm J; Tran E; Berthelet E; Wu J; Olson R; Hamilton SN
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):468-478. PubMed ID: 34004228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.